Regulatory
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Search
Who we are
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
NCF International
Regulatory
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Home
Politics & Business
Page 5
Politics & Business
The importance of IP to boost company’s success
Giuliana Miglierini
-
29 July 2019
Trends for the global pharmaceutical market to 2024
Giuliana Miglierini
-
16 July 2019
The WHA has approved the resolution on transparency of drug prices
Giuliana Miglierini
-
19 June 2019
Biosimilars: the strategic imperative to balance between the needs for innovation...
Giuliana Miglierini
-
15 May 2019
Transforming Big Pharma’s model
Giuliana Miglierini
-
16 April 2019
Horizon Europe: time to look at the future of European research
Giuliana Miglierini
-
21 March 2019
Emerging trends for the pharmaceutical market
Giuliana Miglierini
-
20 February 2019
Inequalities in the access to healthcare in Europe
Giuliana Miglierini
-
15 January 2019
Hard Brexit, soft Brexit, no Brexit?
Giuliana Miglierini
-
11 December 2018
The peril road of the SPC manufacturing waiver
Giuliana Miglierini
-
21 November 2018
1
...
4
5
6
7
Page 5 of 7